Genzyme announces 72,000 sf drug processing plant in Framingham

Genzyme, the Cambridge-based rare diseases arm of French drug giant Sanofi, said Tuesday it plans to build a new $80 million, 72,000 square foot facility in Framingham to help make its drug for the rare, inherited disease, Fabry...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.